^

Health

A
A
A

Stimulated reaction of blast transformation of lymphocytes with mitogens

 
, medical expert
Last reviewed: 18.10.2021
 
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

The values of the stimulated reaction of blastic transformation of lymphocytes in adults are normal: with PHA - 44-72%, with ConA - 40-75%.

The functional activity of T and B lymphocytes is judged by the reaction of blast transformation of lymphocytes with the use of mitogens - PHA, ConA, latex, lipopolysaccharides, etc.

Stimulated blast transformation of lymphocytes with mitogens (PHA, ConA) characterizes the functional ability of T-lymphocytes to transform and multiply under the influence of antigens, allergens and mitogens. Under the influence of mitogens, T cells turn into blasts and divide in response to antigens that enter the body, that is, an increase in the number of T cells occurs in response to mitogens. The functional activity of B-lymphocytes is judged by blast transformation in response to stimulation with lipopolysaccharide, and on mitogen stimulation of latex - on cooperative processes between T and B lymphocytes. Proliferative response of lymphocytes to antigens gives an idea of the severity of specific sensitization of the body. The states and diseases that lead to its change are similar to changes in blast transformation of lymphocytes without stimulation. The test is used for a comprehensive assessment of the patient's immune status.

trusted-source[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14]

Translation Disclaimer: The original language of this article is Russian. For the convenience of users of the iLive portal who do not speak Russian, this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.